In a recent study, researchers sought to examine treatment patterns, healthcare utilization, and costs among patients diagnosed with schizophrenia receiving oral therapy vs long-acting injectable...
While patients with schizophrenia are known to have an increased risk of obesity and metabolic disease, knowledge regarding eating behaviors in this patient population is still limited.
Using National Health Insurance claims data from patients with schizophrenia and type 2 diabetes in Taiwan, researchers sought to investigate the prevalence and characteristics of schizophrenia in this...
The US Food and Drug Administration has approved a shortened version of existing brain stimulation protocol for treatment-resistant major depressive disorder.
In the absence of well-grounded recommendations for the treatment of insomnia in schizophrenia patients, researchers conducted a systematic review of 4 studies that examined the effects of various options...
In order to further clarify the relationship between physical activity and mental health, researchers investigated the psychological effects of exercise vs no exercise, as well as the impact of exercise...
The authors of a new study have identified several medications for ADHD that are most beneficial for children, adolescents, and adults with the disorder.
Researchers assessed the risk for type 2 diabetes among more than 1600 patients with schizophrenia who were treated with first- and second-generation antipsychotics.
The authors of a new study aimed to investigate whether the occurrence of various psychiatric symptoms in mothers and fathers could negatively affect the outcome of their children’s psychopathology.
